CSL reviews

3.4

57% would recommend to a friend

(692 total reviews)
avatar

Gordon Naylor

54% approve of CEO

41% positive business outlook

CSL has an employee rating of 3.4 out of 5 stars, based on 692 company reviews on Glassdoor which indicates that most employees have a good working experience there. The CSL employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).

Reviews by job title

692 reviews
2.0
Jul 13, 2023

Nope

Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Salary Great Group of Reps Veltassa Market Access - NAM team

Cons

Management - in over their heads and overcompensating by micromanaging Sales Ops - had no trust in the numbers provided, missing data for weeks to months Possible layoffs in September Korsuva Terrible IC plans putting low volume achievers at the top because of % growth over previous quarter while high volume territories make almost no bonus 2 ride alongs per month like you’re in beginner sales 101 More concerned about # of calls per day than running business to be successful No diversity on East Management Team

4.0
May 21, 2023
Recommend
CEO approval
Business Outlook

Pros

DEI: ever since the new HR director joins, the company has been better with recognizing female scientists , contractor/admin roles, making sure the workplace is free of harassment/ discrimination. DEI at Seqirus is more employee-led, so it's not perfect. But has good progress. Structure: lean company although CSL is big. Which de-risk the company from lay-offs and etc. I'm glad this company is not "delusional" about growing the company head counts exponentially. Personal Growth: because the company is so lean, young professionals can have individual , semi-impactful projects with mentorship. Colleagues: there are a lot of competent people with good integrity and genuine intentions toward helping others and making the company grow. This is also a place that you can establish life-long friendships, since you work very closely with everyone. Of course, there are a few exceptions which I will not talk in this section. Senior Leadership at the HQ: very competent and smart. They rolled out new EMA/UK MHRA/ FDA approved products every year. However, a lot of the new products they commercialized is through licensing agreement/ collaboration but not through their own R&D department. I'm assuming they are good with strategy development but not the best in terms of R&D from the ground up. Will talk more about that in the cons section.

Cons

1) Pipeline: unsure whether Seqirus wants to be Best In Class or First In Class or just in class? Their vaccines roll-out are quiet slow. For sure, their cell culture manufacturing and differentiated vaccines are unique selling points that provide a cash cow to the company. But new technologies get commercialized at a turtle pace here. Which leads to point number 2. 2) People: some leaders can be micro-managing and instill anxiety. I'm wondering if the people, which are supposedly the assets of the company, are to blame for their slow development pipeline. Of course, there are more factors to that including the company's conservativeness to provide more funding to research. But in this economic climate, it's fair. 3) Strategy: is directly influenced by the current Inflation Reduction Act and company's finances. Some research teams are more favored bc of that; which is sad sometimes.

Viewing 88 - 90 of 692 Reviews

Glassdoor has 911 CSL reviews submitted anonymously by CSL employees. Read employee reviews and ratings on Glassdoor to decide if CSL is right for you.